---
schema_version: "secwatch.filing_event.v1"
accession: "0000730464-25-000007"
form_type: "8-K"
ticker: "CVSA"
cik: "0000730464"
company_name: "Covista Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T06:02:00.224725+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Adtalem Q3 FY2025 EPS $1.59 ($1.92 adj.), revenue $466.1M +12.9%; raises FY guidance

## Summary
- Revenue $466.1M (+12.9% YoY); diluted EPS $1.59 (adj. $1.92, +28% YoY); net income $60.8M.
- Total enrollment up 9.8% to 94,223; Chamberlain +6.8%, Walden +13.5%, Med/Vet +1.2%.
- Completed $300M share repurchase program; new $150M authorization through May 2028.
- FY2025 guidance raised: revenue $1,760-1,775M, adj. EPS $6.40-$6.60 (28-32% YoY growth).
- Adjusted EBITDA $127.8M (+19.3% YoY); margin 27.4% vs 25.9% prior year.

## SEC filing metadata
- accession: 0000730464-25-000007
- form_type: 8-K
- ticker: CVSA
- cik: 0000730464
- company_name: Covista Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/730464/000073046425000007/0000730464-25-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/730464/000073046425000007/atge-20250508x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000730464-25-000007
- JSON: https://secwatch.observer/filing/0000730464-25-000007.json
- Plain text: https://secwatch.observer/filing/0000730464-25-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.